Retinal Disease Therapeutics Market to Rise at 8.6% CAGR and Reach USD 21,318.0 Million by 2026, Facilitated by Increasing Regulatory Approvals for Favouring Drugs, says Fortune Business Insights Pune, Sept. 16, 2020 (GLOBE NEWSWIRE) -- The global retinal disease therapeutics market is likely to expand at an impressive rate driven by recent government participation towards prevention and...